Antimalarial ophthalmological toxicity screening (n = 147 responders).
| Questionnaire Items | Mode (% responders) | Commonly Repeated Strategies (% responders) |
|---|---|---|
| Type of screening for patients with SLE taking antimalarials | Ophthalmology referral (77) | Visual field testing (45), optometry referral (23), other (16), electroretinogram (5) |
| Frequency of ophthalmology/optometry checks for patients with SLE taking antimalarials | Every 6–12 months (71) | Every 13–24 months (26), determined by ophthalmologist/ optometrist (20), dictated by type of antimalarial (5), every 25 to 36 months (2), never (1) |
| % patients who discontinued antimalarial because of related retinopathy | 0–1% of patients (55) | 2–5% patients (33), 6–10% patients (9), other (2), 11–20% patients (1), > 20% patients (0) |
SLE: systemic lupus erythematosus.